43 related articles for article (PubMed ID: 29616117)
1. Improved radiosensitizing effect of the combination of etanidazole and paclitaxel for hepatocellular carcinoma in vivo.
Yang Y; Jin C; Li H; He Y; Liu Z; Bai L; Dou K
Exp Ther Med; 2012 Feb; 3(2):299-303. PubMed ID: 22969885
[TBL] [Abstract][Full Text] [Related]
2. Targeting the Microenvironment in Esophageal Cancer.
Wang L; Han H; Wang Z; Shi L; Yang M; Qin Y
Front Cell Dev Biol; 2021; 9():684966. PubMed ID: 34513829
[TBL] [Abstract][Full Text] [Related]
3. A preclinical study: correlation between PD-L1 PET imaging and the prediction of therapy efficacy of MC38 tumor with
Qin S; Yu Y; Guan H; Yang Y; Sun F; Sun Y; Zhu J; Xing L; Yu J; Sun X
Aging (Albany NY); 2021 Apr; 13(9):13006-13022. PubMed ID: 33910164
[TBL] [Abstract][Full Text] [Related]
4. TGIF1 plays a carcinogenic role in esophageal squamous cell carcinoma through the Wnt/β‑catenin and Akt/mTOR signaling pathways.
Kong L; Yu Y; Guan H; Jiang L; Sun F; Li X; Huang W; Li B
Int J Mol Med; 2021 May; 47(5):. PubMed ID: 33693954
[TBL] [Abstract][Full Text] [Related]
5. Correlation of hypoxia status with radiosensitizing effects of sodium glycididazole: A preclinical study.
Yu Y; Li X; Xu H; Liu J; Dong M; Yang J; Sun L; Sun X; Xing L
Oncol Lett; 2018 May; 15(5):6481-6488. PubMed ID: 29616117
[TBL] [Abstract][Full Text] [Related]
6. Enhanced radiosensitizing by sodium glycididazole in a recurrent esophageal carcinoma tumor model.
Wu P; Liu J; Sun X; Li X; Xing L; Yu J
Oncotarget; 2017 Sep; 8(38):63871-63880. PubMed ID: 28969036
[TBL] [Abstract][Full Text] [Related]
7. The Radiosensitization of Sodium Glycididazole on Nasopharyngeal Carcinoma Cells via Enhancing DNA Damage and Promoting Apoptosis.
Min X; Huang F; Huang H; Zhao S; Wang G; Zhou M; Chen Z; Li M; Chen Y
J Cancer; 2019; 10(2):305-312. PubMed ID: 30719124
[No Abstract] [Full Text] [Related]
8. Immunohistochemical detection of osteopontin in advanced head-and-neck cancer: prognostic role and correlation with oxygen electrode measurements, hypoxia-inducible-factor-1alpha-related markers, and hemoglobin levels.
Bache M; Reddemann R; Said HM; Holzhausen HJ; Taubert H; Becker A; Kuhnt T; Hänsgen G; Dunst J; Vordermark D
Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1481-7. PubMed ID: 17056190
[TBL] [Abstract][Full Text] [Related]
9. Regulation of hypoxia-induced mRNA expressions of HIF-1alpha and osteopontin and in vitro radiosensitization by tirapazamine in human nasopharyngeal carcinoma HNE-1 and CNE-1 cells.
Xu P; Huang JM; Ren Y; Zha X; Deng BF; Wu JH; Lang JY
Chin J Cancer; 2010 Feb; 29(2):126-30. PubMed ID: 20109337
[TBL] [Abstract][Full Text] [Related]
10. Preclinical study on hypoxic radiosensitizing effects of glycididazole in comparison with those of doranidazole
Yasui H; Kubota N; Nishizumi J; Sakai Y; Yamamori T; Inanami O
Oncol Lett; 2018 Feb; 15(2):1993-1998. PubMed ID: 29434899
[TBL] [Abstract][Full Text] [Related]
11. Sodium glycididazole enhances the efficacy of combined iodine-125 seed implantation and chemotherapy in patients with non small-cell lung cancer.
Zhang Q; Wang DQ; Wu YF
Oncol Lett; 2015 May; 9(5):2335-2340. PubMed ID: 26137067
[TBL] [Abstract][Full Text] [Related]
12. IAEA-HypoX. A randomized multicenter study of the hypoxic radiosensitizer nimorazole concomitant with accelerated radiotherapy in head and neck squamous cell carcinoma.
Hassan Metwally MA; Ali R; Kuddu M; Shouman T; Strojan P; Iqbal K; Prasad R; Grau C; Overgaard J
Radiother Oncol; 2015 Jul; 116(1):15-20. PubMed ID: 25913070
[TBL] [Abstract][Full Text] [Related]
13. Predictive value of (18)F-FAZA PET imaging for guiding the association of radiotherapy with nimorazole: a preclinical study.
Tran LB; Bol A; Labar D; Cao-Pham TT; Jordan B; Grégoire V; Gallez B
Radiother Oncol; 2015 Feb; 114(2):189-94. PubMed ID: 25616539
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
